LINC01518

Across TCGA pan-cancer cohorts, LINC01518 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC01518 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher LINC01518 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01518 expression acts as an unfavorable survival marker, although some lineages such as OV and SKCM show a favorable association.

KIRC, MESO, and LIHC are the cancer types where LINC01518 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.512	0.692	<.001	162	view →
MESO	OS	Tertile	IV	0.056	0.640	<.001	90	view →
LIHC	OS	Quartile	II,III,IV	0.466	0.749	<.001	53	view →
OV	OS	Median	IV	0.858	0.492	<.001	50	view →
UVM	OS	Tertile	II,III,IV	0.213	0.712	.005	48	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	45	view →
DLBC	OS	Tertile	All	0.693	0.983	<.001	45	view →
READ	OS	Tertile	II,III,IV	0.739	0.937	.002	45	view →
THCA	DFS	Tertile	All	0.631	0.832	.026	39	view →
SKCM	OS	Median	All	0.411	0.280	<.001	36	view →
LGG	DFS	Tertile	All	0.467	0.750	<.001	36	view →
BRCA	OS	Tertile	III,IV	0.722	0.856	.005	30	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

LINC01518–KIRC (DFS)

Open the KIRC breakdown →